Preparation of substituted acrylate compounds
The reaction of compounds (II) and (III) with a base addresses the limitations of existing methods by achieving high yields and cost-effectiveness in producing substituted acrylate compounds.
Patent Information
- Application Number
- JP2023513453
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2020-08-24
- Filing Date
- 2021-08-23
- Publication Date
- 2024-12-09
- Estimated Expiration
- 2041-08-23
AI Technical Summary
Existing methods for producing substituted acrylate compounds of general formula (I) face issues such as low yields, the need for metal catalysts, and the use of expensive and unsafe raw materials.
A method involving the reaction of a compound of general formula (II) with a compound of general formula (III) in the presence of a base without using a metal catalyst, utilizing inexpensive and readily available materials to achieve high yields.
This method enables the production of substituted acrylate compounds efficiently and safely, suitable for industrial-scale production.
Smart Images

Figure 0007595985000001 
Figure 0007595985000002 
Figure 0007595985000003
Abstract
Description
[Technical field]
[0001] Claiming priority This application claims priority to China Patent Application Publication No. 202010856857.9, filed on August 24, 2020, the disclosure of which is incorporated herein by reference.
[0002] The present disclosure relates to synthetic methods for making substituted acrylate compounds of general formula (I). [Background technology]
[0003] The substituted acrylate compounds of general formula (I) are commonly used pharmaceutical intermediate compounds. [ka]
[0004] Although there are many methods for preparing the compound of general formula (I) in the prior art, they generally suffer from drawbacks such as low yield, the need to use metal catalysts, low safety, expensive raw materials, etc.
[0005] For example, WO2013096771A1 discloses the following reaction without metal catalyst, which involves reacting compound 29a with 2,5-dichlorophenol, K2CO3, and DMF at 120°C for 2 hours in 59% yield (see Example 29 on pages 120-121 of the PCT publication). [ka]
[0006] Thus, there remains a general need to economically, safely, and effectively prepare substituted acrylate compounds of general formula (I). Summary of the Invention [Problem to be solved by the invention]
[0007] As a result of intensive research, the inventors of the present invention have found a process suitable for the industrial production of the compound of general formula (I), which does not require metal catalysts, can be carried out with cheap and readily available raw materials, and produces the compound of general formula (I) in high yield. [Means for solving the problem]
[0008] Specifically, in one embodiment, the method comprises reacting a compound of general formula (II) with a compound of general formula (III) in the presence of a base: [ka]
[0009] During the ceremony,
[0010] Ring A is C 6~10 aryl or 5-10 membered heteroaryl;
[0011] X is S or P;
[0012] R1 is H, C 1~6 Alkyl, C 1~6 Haloalkyl, C 3~7 cycloalkyl, and 3- to 8-membered heterocyclyl;
[0013] R2 is H, C 1~6 Alkyl, and C 1~6 haloalkyl;
[0014] R3 is H, C 1~6 Alkyl, C 1~6 Haloalkyl, C 2~6 Alkenyl, C 2~6 Alkynyl, -C 0~6 Alkylene-C 3~7 Cycloalkyl, -C 0~6 Alkylene-3 to 8-membered heterocyclyl, -C 0~6 Alkylene-C 6~10 Aryl and -C 0~6alkylene-5-10 membered heteroaryl, which are unsubstituted or independently substituted with m R′ groups;
[0015] R4 is C 1~20 Alkyl, C 1~6 Haloalkyl, -OR a , -NR a R b , C 3~7 Cycloalkyl, 3-8 membered heterocyclyl, C 6~10 aryl, and 5-10 membered heteroaryl, which are unsubstituted or independently substituted with m' R'' groups;
[0016] R is H, halogen, -OC 1~6 Alkyl, C 1~6 Alkyl, and C 1~6 haloalkyl;
[0017] n is 0, 1, 2, 3, 4, or 5;
[0018] R' and R'' are independently halogen, -NO2, -CN, -NR a R b , -NR a C(O)R b , C 1~20 Alkyl, C 1~6 Haloalkyl, -OC 1~6 alkyl, and phenyl;
[0019] m is 1, 2, 3, 4, or 5;
[0020] m' is 1, 2, 3, 4, or 5;
[0021] R a and R b are independently H, C 1~6 Alkyl, C 1~6 Haloalkyl, C 3~7 Cycloalkyl, 3-8 membered heterocyclyl, C 6~10 aryl, and 5- to 10-membered heteroaryl, or Ra and R b together with the nitrogen atom to which they are attached, form a 3- to 8-membered heterocyclyl or a 5- to 10-membered heteroaryl.
[0022] In another embodiment, the method does not use a metal catalyst.
[0023] In another embodiment, the method does not use OTf, which is the most commonly used and most reactive leaving group in the art, and can increase the reaction yield compared to when OTf is used.
[0024] In another aspect, the disclosure provides a compound of formula (I) prepared by the process set forth above, [ka]
[0025] During the ceremony,
[0026] Ring A is C 6~10 aryl or 5-10 membered heteroaryl;
[0027] R1 is H, C 1~6 Alkyl, C 1~6 Haloalkyl, C 3~7 cycloalkyl, and 3- to 8-membered heterocyclyl;
[0028] R2 is H, C 1~6 Alkyl, and C 1~6 haloalkyl;
[0029] R3 is H, C 1~6 Alkyl, C 1~6 Haloalkyl, C 2~6 Alkenyl, C 2~6 Alkynyl, -C 0~6 Alkylene-C 3~7 Cycloalkyl, -C 0~6 Alkylene-3 to 8-membered heterocyclyl, -C 0~6 Alkylene-C 6~10Aryl and -C 0~6 alkylene-5-10 membered heteroaryl, which are unsubstituted or independently substituted with m R′ groups;
[0030] R is H, halogen, -OC 1~6 Alkyl, C 1~6 Alkyl, and C 1~6 haloalkyl;
[0031] n is 0, 1, 2, 3, 4, or 5;
[0032] R' is halogen, -NO2, -CN, -NR a R b , -NR a C(O)R b , C 1~20 Alkyl, C 1~6 Haloalkyl, -OC 1~6 alkyl, and phenyl;
[0033] m is 1, 2, 3, 4, or 5;
[0034] R a and R b are independently H, C 1~6 Alkyl, C 1~6 Haloalkyl, C 3~7 Cycloalkyl, 3-8 membered heterocyclyl, C 6~10 aryl, and 5- to 10-membered heteroaryl, or R a and R b together with the nitrogen atom to which they are attached, form a 3- to 8-membered heterocyclyl or a 5- to 10-membered heteroaryl. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0035] definition
[0036] chemical definition
[0037] Definitions of specific functional groups and chemical terms are discussed in more detail below.
[0038] When a range of values is listed, it is intended to encompass each value and subrange within that range. For example, "C 1~6 Alkyl" is C1, C2, C3, C4, C5, C6, C 1~6 , C 1~5 , C 1~4 , C 1~3 , C 1~2 , C 2~6 , C 2~5 , C 2~4 , C 2~3 , C 3~6 , C 3~5 , C 3~4 , C 4~6 , C 4~5 , and C 5~6 It is intended to include alkyl.
[0039] The term "about" means having a value that falls within the accepted standard error of the mean when considered by one of ordinary skill in the art. For example, "about" means ±10% of the indicated value or ±5% of the indicated value.
[0040] "C 1~20 "Alkyl" refers to the radical of a linear or branched saturated hydrocarbon group having 1 to 20 carbon atoms. In some embodiments, another option is C 1~12 In some embodiments, another option is C 1~6 In some embodiments, another option is C 1~4 It is an alkyl group. 1~6 Examples of alkyl include methyl (C1), ethyl (C2), n-propyl (C3), iso-propyl (C3), n-butyl (C4), tert-butyl (C4), sec-butyl (C4), iso-butyl (C4), n-pentyl (C5), 3-pentyl (C5), pentyl (C5), neopentyl (C5), 3-methyl-2-butyl (C5), tert-pentyl (C5), and n-hexyl (C6). 1~6The term "alkyl" also includes heteroalkyl, in which one or more (e.g., 1, 2, 3, or 4) carbon atoms are replaced with a heteroatom (e.g., oxygen, sulfur, nitrogen, boron, silicon, phosphorus). Alkyl groups can be optionally substituted with one or more substituents, for example, 1 to 5 substituents, 1 to 3 substituents, or 1 substituent. Conventional abbreviations for alkyl include Me(-CH3), Et(-CH2CH3), iPr(-CH(CH3)2), nPr(-CH2CH2CH3), nBu(-CH2CH2CH2CH3), or iBu(-CH2CH(CH3)2).
[0041] "C 2~6 "Alkenyl" refers to a radical of a straight or branched chain hydrocarbon group having 2 to 6 carbon atoms and at least one carbon-carbon double bond. In some embodiments, another option is C 2~4 Alkenyl. 2~6 Examples of alkenyl include biphenyl. Examples of aryl include 1-propenyl (C2), 1-propenyl (C3), 2-propenyl (C3), 1-butenyl (C4), 2-butenyl (C4), butadienyl (C4), pentenyl (C5), pentadienyl (C5), and hexenyl (C6). 2~6 The term "alkenyl" also includes heteroalkenyl in which one or more (e.g., 1, 2, 3, or 4) carbon atoms are replaced with a heteroatom (e.g., oxygen, sulfur, nitrogen, boron, silicon, phosphorus). Alkenyl groups can be optionally substituted with one or more substituents, for example, 1 to 5 substituents, 1 to 3 substituents, or 1 substituent.
[0042] "C 2~6 "Alkynyl" refers to a radical of a linear or branched hydrocarbon group having 2 to 6 carbon atoms, at least one carbon-carbon triple bond, and optionally one or more carbon-carbon double bonds. In some embodiments, another option is C 2~4 Alkynyl. 2~6Examples of alkynyl include, but are not limited to, ethynyl (C2), 1-propynyl (C3), 2-propynyl (C3), 1-butynyl (C4), 2-butynyl (C4), pentynyl (C5), hexynyl (C6), and the like. 2~6 The term "alkynyl" also includes heteroalkynyl groups in which one or more (e.g., 1, 2, 3, or 4) carbon atoms are replaced with a heteroatom (e.g., oxygen, sulfur, nitrogen, boron, silicon, phosphorus). Alkynyl groups can be optionally substituted with one or more substituents, for example, 1 to 5 substituents, 1 to 3 substituents, or 1 substituent.
[0043] "C 1~6 Alkylene is defined as "C 1~6 A divalent group of "alkyl", i.e., C 1~6 means a divalent group formed by removing another hydrogen from an alkyl, which may be a substituted or unsubstituted alkylene. In some embodiments, yet another option is C 1~4 Alkylene. Unsubstituted alkylene groups include, but are not limited to, methylene (-CH-), ethylene (-CHCH-), propylene (-CHCHCH-), butylene (-CHCHCHCHCH-), pentylene (-CHCHCHCHCHCH-), hexylene (-CHCHCHCHCHCHCH-), and the like. Examples of substituted alkylene groups, such as those substituted with one or more alkyl (methyl) groups, include, but are not limited to, substituted methylene (-CH(CH3)-, -C(CH3)2-), substituted ethylene (-CH(CH3)CH2-, -CH2CH(CH3)-, -C(CH3)2CH2-, -CH2C(CH3)2-), substituted propylene (-CH(CH3)CH2CH2-, -CH2CH(CH3)CH2-, -CH2CH2CH(CH3)CH2-, -CH2CH2CH(CH3)-, -C(CH3)2CH2CH2-, -CH2C(CH3)2CH2-, -CH2CH2C(CH3)2-), and the like.
[0044] "C 0~6 Alkylene is a chemical bond and a "C 1~6means "alkylene".
[0045] "Halo" or "halogen" means fluorine (F), chlorine (Cl), bromine (Br), and iodine (I).
[0046] Therefore, "C 1~6 Haloalkyl refers to the above C substituted with one or more halogens. 1~6 In some embodiments, still another option is C 1~4 haloalkyl, and another option is C 1~2 haloalkyl. Exemplary haloalkyl groups include, but are not limited to, -CF3, -CH2F, -CHF2, -CHFCH2F, -CH2CHF2, -CF2CF3, -CCl3, -CH2Cl, -CHCl2, 2,2,2-trifluoro-1,1-dimethyl-ethyl, and the like. Haloalkyl groups can be optionally substituted at any available point of attachment with, for example, 1 to 5 substituents, 1 to 3 substituents, or 1 substituent.
[0047] "C 3~7 "Cycloalkyl" refers to a radical of a non-aromatic cyclic hydrocarbon group having 3 to 7 ring carbon atoms and no heteroatoms. In some embodiments, another option is C 3~5 In another embodiment, another option is C 3~6 In another embodiment, another option is C 5~6Cycloalkyl. Cycloalkyl also includes ring systems in which a cycloalkyl as described herein is fused to one or more aryl or heteroaryl groups, with the point of attachment being on the cycloalkyl ring, in which case the number of carbon atoms continues to represent the number of carbon atoms in the cycloalkyl system. Exemplary cycloalkyl groups include, but are not limited to, cyclopropyl (C3), cyclopropenyl (C3), cyclobutyl (C4), cyclobutenyl (C4), cyclopentyl (C5), cyclopentenyl (C5), cyclohexyl (C6), cyclohexenyl (C6), cyclohexadienyl (C6), cycloheptyl (C7), cycloheptenyl (C7), cycloheptadienyl (C7), cycloheptatrienyl (C7), and the like. Cycloalkyl may be substituted with one or more substituents, for example, 1-5 substituents, 1-3 substituents, or 1 substituent.
[0048] "3- to 8-membered heterocyclyl" means a radical of a 3- to 8-membered non-aromatic ring system having ring carbon atoms and 1 to 4 ring heteroatoms. Another option is 3- to 6-membered heterocyclyl, which is a radical of a 3- to 6-membered non-aromatic ring system having ring carbon atoms and 1 to 3 ring heteroatoms. Another option is 3- to 5-membered heterocyclyl, which is a radical of a 3- to 5-membered non-aromatic ring system having ring carbon atoms and 1 to 2 ... An option is 4-8 membered heterocyclyl, which is a radical of a 4-8 membered non-aromatic ring system having ring carbon atoms and 1-3 ring heteroatoms. Yet another option is 5-6 membered heterocyclyl, which is a radical of a 5-6 membered non-aromatic ring system having ring carbon atoms and 1-3 ring heteroatoms. Heterocyclyl also includes ring systems in which the above-mentioned heterocyclyl is fused to one or more cycloalkyl groups, the attachment point of which is on the cycloalkyl ring, or the above-mentioned heterocyclyl is fused to one or more aryl or heteroaryl groups, the attachment point of which is on the heterocyclyl ring, in which case the number of ring atoms continues to represent the number of ring atoms in the heterocyclyl ring system. Exemplary 3-membered heterocyclyl groups containing one heteroatom include, but are not limited to, aziridinyl, oxiranyl, and thiiranyl (thiorenyl). Exemplary 4-membered heterocyclyl groups containing one heteroatom include, but are not limited to, azetidinyl, oxetanyl, and thietanyl. Exemplary 5-membered heterocyclyl groups containing one heteroatom include, but are not limited to, tetrahydrofuranyl, dihydrofuranyl, tetrahydrothiophenyl, dihydrothienyl, pyrrolidinyl, dihydropyrrolyl, and pyrrolyl-2,5-dione. Exemplary 5-membered heterocyclyl groups containing two heteroatoms include, but are not limited to, dioxolanyl, oxasulfuranyl, disulfuranyl, and oxazolidin-2-one. Exemplary 5-membered heterocyclyl groups containing three heteroatoms include, but are not limited to, triazolinyl, oxadiazolinyl, and thiadiazolinyl. Exemplary 6-membered heterocyclyl groups containing one heteroatom include, but are not limited to, piperidyl, tetrahydropyranyl, dihydropyridyl, and thianyl. Exemplary 6-membered heterocyclyl groups containing two heteroatoms include, but are not limited to, piperazinyl, morpholinyl, dithianyl, and dioxanyl.Exemplary 6-membered heterocyclyl groups containing three heteroatoms include, but are not limited to, triazinanyl. Exemplary 7-membered heterocyclyl groups containing one heteroatom include, but are not limited to, azepanyl, oxepanyl, and thiepanyl. Exemplary 5-membered heterocyclyl groups fused to a C6 aryl (also referred to herein as 5,6-bicyclic heterocyclyl) include, but are not limited to, indolinyl, isoindolinyl, dihydrobenzofuranyl, dihydrobenzothiophenyl, benzoxazolinonyl, and the like. Exemplary 6-membered heterocyclyl groups fused to a C6 aryl (also referred to herein as 6,6-bicyclic heterocyclyl) include, but are not limited to, tetrahydroquinolinyl, tetrahydroisoquinolinyl, and the like. The heterocyclyl may be substituted with one or more substituents, for example, 1 to 5 substituents, 1 to 3 substituents, or 1 substituent.
[0049] "C 6~10 "Aryl" refers to a radical of a monocyclic or polycyclic (e.g., bicyclic) 4n+2 aromatic ring system having 6 to 10 ring carbon atoms and no heteroatoms (e.g., having 6 or 10 shared pi electrons in a ring array). In some embodiments, an aryl group has 6 ring carbon atoms ("C6 aryl", e.g., phenyl). In some embodiments, an aryl group has 10 ring carbon atoms ("C 10 "Aryl", e.g. naphthyl, e.g. 1-naphthyl and 2-naphthyl. Aryl groups also include ring systems in which the aryl ring as described above is fused to one or more cycloalkyl or heterocyclyl groups, the point of attachment being on the aryl ring, in which case the number of carbon atoms continues to represent the number of carbon atoms in the aryl ring system. Aryl may be substituted with one or more substituents, e.g. 1 to 5 substituents, 1 to 3 substituents, or 1 substituent.
[0050] "5-10 membered heteroaryl" refers to a 5-10 membered monocyclic or polycyclic 4n+2 aromatic ring system (e.g., 6 or 10 covalent rings in a ring array) having ring carbon atoms and 1 to 4 ring heteroatoms. having π electrons), where each heteroatom is independently selected from nitrogen, oxygen, and sulfur. In heteroaryl groups containing one or more nitrogen atoms, the point of attachment can be a carbon or nitrogen atom, provided that valence allows. Heteroaryl bicyclic ring systems can contain one or more heteroatoms in one or both rings. Heteroaryl also includes ring systems in which the heteroaryl ring as described above is fused to one or more cycloalkyl or heterocyclyl groups, and the point of attachment is on the heteroaryl ring. In such cases, the number of carbon atoms continues to represent the number of carbon atoms in the heteroaryl ring system. In some embodiments, yet another option is a 5-6 membered heteroaryl group, which is a radical of a 5-6 membered monocyclic or bicyclic 4n+2 aromatic ring system having ring carbon atoms and 1-4 ring heteroatoms. Exemplary 5 membered heteroaryl groups containing one heteroatom include, but are not limited to, pyrrolyl, furyl, and thienyl. Exemplary 5-membered heteroaryl groups containing two heteroatoms include, but are not limited to, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, and isothiazolyl. Exemplary 5-membered heteroaryl groups containing three heteroatoms include, but are not limited to, triazolyl, oxadiazolyl (such as 1,2,4-oxadiazolyl), and thiadiazolyl. Exemplary 5-membered heteroaryl groups containing four heteroatoms include, but are not limited to, tetrazolyl. Exemplary 6-membered heteroaryl groups containing one heteroatom include, but are not limited to, pyridyl. Exemplary 6-membered heteroaryl groups containing two heteroatoms include, but are not limited to, pyridazinyl, pyrimidinyl, and pyrazinyl. Exemplary 6-membered heteroaryl groups containing three or four heteroatoms include, but are not limited to, triazinyl and tetrazinyl, respectively. Exemplary seven-membered heteroaryl groups containing one heteroatom include, but are not limited to, azepinyl, oxepinyl, and thiepinyl.Exemplary 5,6 bicyclic heteroaryl groups include, but are not limited to, indolyl, isoindolyl, indazolyl, benzotriazolyl, benzothiophenyl, isobenzothiophenyl, benzofuranyl, benzoisofuranyl, benzimidazolyl, benzoxazolyl, benzoisoxazolyl, benzoxadiazolyl, benzothiazolyl, benzoisothiazolyl, benzothiadiazolyl, indolizinyl, and purinyl. Exemplary 6,6 bicyclic heteroaryl groups include, but are not limited to, naphthyridinyl, pteridinyl, quinolyl, isoquinolyl, cinnolinyl, quinoxalinyl, phthalazinyl, and quinazolinyl. Heteroaryl may be substituted with one or more substituents, for example, 1 to 5 substituents, 1 to 3 substituents, or 1 substituent.
[0051] Alternatively, illustrative heteroaryl groups include pyrrolyl, imidazolyl, pyrazolyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, pyrimidinyl, pyrazinyl, pyridazinyl, triazolyl (4H-1,2,4-triazolyl, 1H-1,2,3-triazolyl, 2H-1,2,3-triazolyl, pyranyl, 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, oxazolyl, isoxazolyl, oxazolyl (1,2,4-oxazolyl, 1,3,4-oxazolyl, 1,2,5-oxazolyl), thiazolyl, thiadiazolyl (1,2,4-thiadiazolyl, 1,3,4-thiadiazolyl, 1,2,5-thiadiazolyl).
[0052] As defined herein, alkyl, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, and heteroaryl are optionally substituted groups.
[0053] Exemplary substituents on carbon atoms include, but are not limited to, halogen, -CN, -NO2, -N3, -SO2H, -SO3H, -OH, -OR aa , -ON( R bb )2, -N(R bb)2、-N(R bb )3 + X - 、-N(OR cc )R bb 、-SH、-SR aa 、-SSR cc 、-C(=O)R aa 、-CO2H、-CHO、-C(OR cc )2、-CO2R aa 、-OC(=O)R aa 、-OCO2R aa 、-C(=O)N(R bb )2、-OC(=O)N(R bb )2、-NR bb C(=O)R aa 、-NR bb CO2R aa 、-NR bb C(=O)N(R bb )2、-C(=NR bb )R aa 、-C(=NR bb )OR aa 、-OC(=NR bb )R aa 、-OC(=NR bb )OR aa 、-C(=NR bb )N(R bb )2、-OC(=NR bb )N(R bb )2、-NR bb C(=NR bb )N(R bb )2、-C(=O)NR bb SO2R aa 、-NR bb SO2R aa 、-SO2N(R bb )2、-SO2R aa 、-SO2OR aa 、-OSO2R aa 、-S(=O)R aa 、-OS(=O)R aa 、-Si(R aa )3、-OSi(R aa )3、-C(=S)N(R bb )2、-C(=O)SR aa 、-C(=S)SR aa 、-SC(=S)SRaa , -SC(=O)SR aa , -OC(=O)SR aa , -SC(=O)OR aa , -SC(=O)R aa , -P(=O)2R aa , -OP(=O)2R aa , -P(=O)(R aa )2, -OP(=O)(R aa )2, -OP(=O)(OR cc )2, -P(=O)2N(R bb )2, -OP(=O)2N(R bb )2, -P(=O)(NR bb )2, -OP(=O)(NR bb )2, -NR bb P(=O)(OR cc )2, -NR bb P(=O)(NR bb )2, -P(R cc )2, -P(R cc )3, -OP(R cc )2, -OP(R cc )3, -B(R aa )2, -B(OR cc )2, -BR aa (OR cc ), alkyl, haloalkyl, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, and heteroaryl, each of which independently comprises 0, 1, 2, 3, 4, or 5 R dd is substituted with a group,
[0054] Or, the two geminal hydrogens on the carbon atom are =O, =S, =NN(R bb )2, =NNR bb C(=O)R aa , =NNR bb C(=O)OR aa , =NNR bb S(=O)2R aa , =NR bb , or =NOR cc is replaced by a group,
[0055] R aa each is independently selected from alkyl, haloalkyl, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, and heteroaryl, or R aa When two of the groups are combined to form a heterocyclyl or heteroaryl ring, each of the alkyl, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, and heteroaryl independently has 0, 1, 2, 3, 4, or 5 R dd is substituted with a group,
[0056] R bb each independently represents hydrogen, -OH, -OR aa , -N(R cc )2, -CN, -C(=O)R aa , -C(=O)N(R cc )2, -CO2R aa , -SO2R aa , -C(=NR cc ) OR aa , -C(=NR cc )N(R cc )2, -SO2N(R cc )2, -SO2R cc , -SO2OR cc , -SOR aa , -C(=S)N(R cc )2, -C(=O)SR cc , -C(=S)SR cc , -P(=O)2R aa , -P(=O)(R aa )2, -P(=O)2N(R cc )2, -P(=O)(NR cc 2, alkyl, haloalkyl, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, and heteroaryl, or two R bb When the groups are combined to form a heterocyclyl or heteroaryl ring, each of the alkyl, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, and heteroaryl independently has 0, 1, 2, 3, 4, or 5 R dd is substituted with a group,
[0057] R cc each is independently selected from hydrogen, alkyl, haloalkyl, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, and heteroaryl, or two R cc The groups taken together to form a heterocyclyl or heteroaryl ring include alkyl, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, and Each heteroaryl independently has 0, 1, 2, 3, 4, or 5 R dd is substituted with a group,
[0058] R dd each independently represents a halogen, -CN, -NO2, -N3, -SO2H, -SO3H, -OH, -OR ee , -ON(R ff )2, -N(R ff )2, -N(R ff )3 + X - , -N(OR ee )R ff , -SH, -SR ee , -SSR ee , -C(=O)R ee , -CO2H, -CO2R ee , -OC(=O)R ee , -OCO2R ee , -C(=O)N(R ff )2, -OC(=O)N(R ff )2, -NR ff C(=O)R ee , -NR ff CO2R ee , -NR ff C(=O)N(R ff )2, -C(=NR ff ) OR ee , -OC(=NR ff )R ee , -OC(=NR ff ) OR ee , -C(=NR ff )N(R ff )2, -OC(=NR ff )N(R ff )2, -NR ff C(=NRff )N(R ff )2, -NR ff SO2R ee , -SO2N(R ff )2, -SO2R ee , -SO2OR ee , -OSO2R ee , -S(=O)R ee , -Si(R ee )3, -OSi(R ee )3, -C(=S)N(R ff )2, -C(=O)SR ee , -C(=S)SR ee , -SC(=S)SR ee , -P(=O)2R ee , -P(=O)(R ee )2, -OP(=O)(R ee )2, -OP(=O)(OR ee 2, alkyl, haloalkyl, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, and heteroaryl, each of which is independently selected from 0, 1, 2, 3, 4, or 5 R gg or two geminal R dd the substituents may combine to form =O or =S;
[0059] R ee each is independently selected from alkyl, haloalkyl, alkenyl, alkynyl, carbocyclyl, aryl, heterocyclyl, and heteroaryl, and each of alkyl, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, and heteroaryl is independently selected from 0, 1, 2, 3, 4, or 5 R gg is substituted with a group,
[0060] R ff each is independently selected from hydrogen, alkyl, haloalkyl, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, and heteroaryl, or two R ffWhen the groups are combined to form a heterocyclyl or heteroaryl ring, each of the alkyl, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, and heteroaryl independently has 0, 1, 2, 3, 4, or 5 R gg is substituted with a group,
[0061] R gg each independently represents a halogen, -CN, -NO2, -N3, -SO2H, -SO3H, -OH, -OC 1~6 Alkyl, -ON(C 1~6 alkyl)2, -N(C 1~6 alkyl)2, -N(C 1~6 Alkyl)3 + X - , -NH(C 1~6 Alkyl)2 + X - , -NH2(C 1~6 Alkyl) + X - , -NH3 + X - , -N(OC 1~6 Alkyl)(C 1~6 alkyl), -N(OH)(C 1~6 alkyl), -NH(OH), -SH, -SC 1~6 Alkyl, -SS(C 1~6 alkyl), -C(=O)(C 1~6 alkyl), -CO2H, -CO2(C 1~6 alkyl), -OC(=O)(C 1~6 alkyl), -OCO2(C 1~6 alkyl), -C(=O)NH2, -C(=O)N(C 1~6 alkyl)2, -OC(=O)NH(C 1~6 alkyl), -NHC(=O)(C 1~6 alkyl), -N(C 1~6 Alkyl)C(=O)(C 1~6 alkyl), -NHCO2(C 1~6 alkyl), -NHC(=O)N(C 1~6 alkyl)2, -NHC(=O)NH(C 1~6 alkyl), -NHC(=O)NH2, -C(=NH)O(C 1~6alkyl), -OC(=NH)(C 1~6 alkyl), -OC(=NH)OC 1~6 Alkyl, -C(=NH)N(C 1~6 alkyl)2, -C(=NH)NH(C 1~6 alkyl), -C(=NH)NH2, -OC(=NH)N(C 1~6 alkyl)2, -OC(NH)NH(C 1~6 alkyl), -OC(NH)NH2, -NHC(NH)N(C 1~6 a -NHC(=NH)NH2, -NHSO2(C 1~6 Alkyl), -SO2N(C 1~6 Alkyl)2, -SO2NH(C 1~6 Alkyl), -SO2NH2, -SO2C 1~6 Alkyl, -SO2OC 1~6 Alkyl, -OSO2C 1~6 Alkyl, -SOC 1~6 Alkyl, -Si(C 1~6 alkyl)3, -OSi(C 1~6 Alkyl)3, -C(=S)N(C 1~6 alkyl)2, C(=S)NH(C 1~6 alkyl), C(=S)NH2, -C(=O)S(C 1~6 Alkyl), -C(=S)SC 1~6 Alkyl, -SC(=S)SC 1~6 Alkyl, -P(=O)2(C 1~6 alkyl), -P(=O)(C 1~6 alkyl)2, -OP(=O)(C 1~6 Alkyl)2, -OP(=O)(OC 1~6 Alkyl)2, C 1~6 Alkyl, C 1~6 Haloalkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C7 carbocyclyl, C6-C 10 Aryl, C3-C7 heterocyclyl, C5-C 10 heteroaryl, or two geminal R gg The substituents may combine to form =O or =S, X - is the counter ion.
[0062] Exemplary substituents on a nitrogen atom include, but are not limited to, hydrogen, -OH, -OR aa , -N(R cc )2, -CN, -C(=O)R aa , -C(=O)N(R cc )2, -CO2R aa , -SO2R aa , -C(=NR bb ) OR aa , -C(=NR cc ) OR aa , -C(=NR cc )N(R cc )2, -SO2N(R cc )2, -SO2R cc , -SO2OR cc , -SOR aa , -C(=S)N(R cc )2, -C(=O)SR cc , -C(=S)SR cc , -P(=O)2R aa , -P(=O)(R aa )2, -P(=O)2N(R cc )2, -P(=O)(NR cc ) 2, alkyl, haloalkyl, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, and heteroaryl; or two R cc When the groups are combined to form a heterocyclyl or heteroaryl ring, each of the alkyl, alkenyl, alkynyl, carbocyclyl, heterocyclyl, aryl, and heteroaryl independently has 0, 1, 2, 3, 4, or 5 R dd is substituted with an R aa , R bb , R cc , and R dd is as described herein.
[0063] Specific embodiments In one embodiment, the present disclosure relates to a method for preparing a compound of general formula (I), comprising reacting a compound of general formula (II) with a compound of general formula (III) in the presence of a base; [ka]
[0064] During the ceremony,
[0065] Ring A is C 6~10 aryl or 5-10 membered heteroaryl;
[0066] X is S or P;
[0067] R1 is H, C 1~6 Alkyl, C 1~6 Haloalkyl, C 3~7 cycloalkyl, and 3- to 8-membered heterocyclyl;
[0068] R2 is H, C 1~6 Alkyl, and C 1~6 haloalkyl;
[0069] R3 is H, C 1~6 Alkyl, C 1~6 Haloalkyl, C 2~6 Alkenyl, C 2~6 Alkynyl, -C 0~6 Alkylene-C 3~7 Cycloalkyl, -C 0~6 Alkylene-3 to 8-membered heterocyclyl, -C 0~6 Alkylene-C 6~10 Aryl and -C 0~6 alkylene-5-10 membered heteroaryl, which are unsubstituted or independently substituted with m R′ groups;
[0070] R4 is C 1~20 Alkyl, C 1~6 Haloalkyl, -OR a , -NR a R b , C 3~7 Cycloalkyl, 3-8 membered heterocyclyl, C 6~10 aryl, and 5-10 membered heteroaryl, which are unsubstituted or independently substituted with m' R'' groups;
[0071] R is H, halogen, -OC 1~6 Alkyl, C 1~6 Alkyl, and C 1~6 haloalkyl;
[0072] n is 0, 1, 2, 3, 4, or 5;
[0073] R' and R'' are independently halogen, -NO2, -CN, -NR a R b , -NR a C(O)R b , C 1~20 Alkyl, C 1~6 Haloalkyl, -OC 1~6 alkyl, and phenyl;
[0074] m is 1, 2, 3, 4, or 5;
[0075] m' is 1, 2, 3, 4, or 5;
[0076] R a and R b are independently H, C 1~6 Alkyl, C 1~6 Haloalkyl, C 3~7 Cycloalkyl, 3-8 membered heterocyclyl, C 6~10 aryl, and 5- to 10-membered heteroaryl, or R a and R b together with the nitrogen atom to which they are attached, form a 3- to 8-membered heterocyclyl or a 5- to 10-membered heteroaryl.
[0077] Ring A
[0078] In certain embodiments, ring A is C 6~10In another specific embodiment, ring A is aryl; in another specific embodiment, ring A is a 5-10 membered heteroaryl; in another specific embodiment, ring A is phenyl; in another specific embodiment, ring A is naphthyl; in another specific embodiment, ring A is a 5-6 membered heteroaryl; and in another specific embodiment, ring A is thienyl.
[0079] X
[0080] In a specific embodiment, X is S; in another specific embodiment, X is P.
[0081] R1
[0082] In a specific embodiment, R is H, and in another specific embodiment, R is C 1~6 In another specific embodiment, R is alkyl, and in another specific embodiment, R is methyl, and in another specific embodiment, R is C 1~6 In another specific embodiment, R is C 3~7 cycloalkyl, and in another specific embodiment, R1 is 3-8 membered heterocyclyl.
[0083] R2
[0084] In a specific embodiment, R2 is H, and in another specific embodiment, R2 is C 1~6 In another specific embodiment, R is C 1~6 It is haloalkyl.
[0085] R3
[0086] In a specific embodiment, R3 is H, and in another specific embodiment, R3 is C 1~6 In another specific embodiment, R3 is alkyl; in another specific embodiment, R3 is ethyl; in another specific embodiment, R3 is t-butyl; and in another specific embodiment, R3 is C 1~6 In another specific embodiment, R is C 2~6alkenyl, and in another specific embodiment, R3 is C 2~6 In another specific embodiment, R is -C 0~6 Alkylene-C 3~7 In another specific embodiment, R is -C 0~6 In another specific embodiment, R3 is -C 0~6 Alkylene-C 6~10 aryl, and in another specific embodiment, R3 is -C 0~6 alkylene-5-10 membered heteroaryl, and in another specific embodiment, R3 is benzyl. In the above specific embodiment, the group is unsubstituted or independently substituted with m R' groups.
[0087] R4
[0088] In specific embodiments, R4 is C 1~20 In another specific embodiment, R is C 1~12 In another specific embodiment, R is C 1~6 In another specific embodiment, R is C 1~6 haloalkyl; in another specific embodiment, R4 is -OR a In another specific embodiment, R4 is -NR a R b In another specific embodiment, R4 is C 3~7 In another specific embodiment, R4 is cycloalkyl, and in another specific embodiment, R4 is 3-8 membered heterocyclyl, and in another specific embodiment, R4 is C 6~10 In another specific embodiment, R4 is aryl, and in another specific embodiment, R4 is phenyl, and in another specific embodiment, R4 is 5-10 membered heteroaryl. In the above specific embodiment, the group is unsubstituted or independently substituted with m' R'' groups.
[0089] R' and R''
[0090] In a specific embodiment, R' is halogen; in another specific embodiment, R' is chloro; in another specific embodiment, R' is -NO2; in another specific embodiment, R' is -CN; in another specific embodiment, R' is -NR a R b In another specific embodiment, R′ is —NR a C(O)R b In another specific embodiment, R′ is C 1~20 In another specific embodiment, R′ is C 1~12 In another specific embodiment, R′ is C 1~6 In another specific embodiment, R' is alkyl, and in another specific embodiment, R' is methyl, and in another specific embodiment, R' is C 1~6 haloalkyl, and in another specific embodiment, R' is -OC 1~6 alkyl, and in another specific embodiment, R' is phenyl.
[0091] In a specific embodiment, R'' is halogen; in another specific embodiment, R'' is chloro; in another specific embodiment, R'' is -NO2; in another specific embodiment, R'' is -CN; in another specific embodiment, R'' is -NR a R b In another specific embodiment, R″ is —NR a C(O)R b and In another specific embodiment, R″ is C 1~20 In another specific embodiment, R″ is C 1~12 In another specific embodiment, R″ is C 1~6 In another specific embodiment, R'' is alkyl, and in another specific embodiment, R'' is methyl, and in another specific embodiment, R'' is C 1~6 haloalkyl, and in another specific embodiment, R″ is —OC 1~6 In another specific embodiment, R'' is phenyl.
[0092] In the specific embodiment above, R a and R b are independently H, C 1~6 Alkyl, and C 1~6 haloalkyl.
[0093] m
[0094] In a specific embodiment, m is 0; in another specific embodiment, m is 1; in another specific embodiment, m is 2; in another specific embodiment, m is 3; in another specific embodiment, m is 4; and in another specific embodiment, m is 5.
[0095] m'
[0096] In a specific embodiment, m' is 0; in another specific embodiment, m' is 1; in another specific embodiment, m' is 2; in another specific embodiment, m' is 3; in another specific embodiment, m' is 4; and in another specific embodiment, m' is 5.
[0097] R
[0098] In a specific embodiment, R is H; in another specific embodiment, R is halogen; in another specific embodiment, R is chloro; in another specific embodiment, R is -OC 1~6 In another specific embodiment, R is C 1~6 In another specific embodiment, R is C 1~6 It is haloalkyl.
[0099] n
[0100] In a specific embodiment, n is 0; in another specific embodiment, n is 1; in another specific embodiment, n is 2; in another specific embodiment, n is 3; in another specific embodiment, n is 4; and in another specific embodiment, n is 5.
[0101] Any technical solution or any combination thereof in any one of the above specific embodiments may be combined with any technical solution or any combination thereof in other specific embodiments. For example, any technical solution or any combination thereof for X may be combined with any technical solution or any combination thereof for ring A, R1-R4, R, R', R'', m, m', n, etc. The present disclosure is intended to include all combinations of such technical solutions, which are not exhaustively listed here for the sake of space.
[0102] In a more specific embodiment, the present disclosure provides the above method, wherein X is S.
[0103] In a more specific embodiment, the present disclosure provides a C 6~10 The above method is provided in the case where the ring is aryl or 5- to 10-membered heteroaryl.
[0104] In a more specific embodiment, the present disclosure provides a method for the preparation of a fluorophenyl aryl group, wherein R4 is selected from the group consisting of phenyl, 1-naphthyl, 2-naphthyl, 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl, 2-bromophenyl, 3-bromophenyl, 4-bromophenyl, 2-fluorophenyl, 3-fluorophenyl, 4-fluorophenyl, 2,6-dichlorophenyl, 2,4-difluorophenyl, 3-cyanophenyl, 4-cyanophenyl, 2-nitrophenyl, 4-nitrophenyl, 2-methylphenyl, 4-methylphenyl, 4-propylphenyl, 4-t-butylphenyl, 2,5-dimethylphenyl, mesityl, 2,4,6-triisopropylphenyl, 2-dodecylphenyl, 3-dodecylphenyl, 4-dodecylphenyl, 2-(trifluoromethyl)phenyl, 3-(trifluoromethyl)phenyl, 3,5-bis(trifluoromethyl)phenyl, 2- ... wherein R4 is selected from phenyl, 1-naphthyl, 2-naphthyl, 4-chlorophenyl, 3-fluorophenyl, 4-fluorophenyl, 4-nitrophenyl, 2-methylphenyl, 4-propylphenyl, 4-t-butylphenyl, 2,5-dimethylphenyl, 2,4,6-triisopropylphenyl, 2-dodecylphenyl, 3-dodecylphenyl, 4-dodecylphenyl, 4-methoxyphenyl, 4-acetylaminophenyl, 4-biphenyl, thienyl, and 5-bromothienyl; wherein R4 is selected from phenyl, 1-naphthyl, 2-naphthyl, 4-chlorophenyl, 3-fluorophenyl, 4-fluorophenyl, 4-nitrophenyl, 2-methylphenyl, 4-propylphenyl, 4-t-butylphenyl, 2,5-dimethylphenyl, 2,4,6-triisopropylphenyl, 2-dodecylphenyl, 3-dodecylphenyl, 4-dodecylphenyl, 4-methoxyphenyl, 4-acetylaminophenyl, 4-methylphenyl, and mesityl; and wherein R4 is selected from phenyl, 4-chlorophenyl, 4-methylphenyl, and mesityl.
[0105] In a more specific embodiment, the present disclosure provides a C 1~12 Alkyl, -OR a , -NR a R b , C 3~7 The above method is provided in the case where the ring is a cycloalkyl or a 3- to 8-membered heterocyclyl.
[0106] In a more specific embodiment, the present disclosure provides the above method, wherein R4 is selected from N,N-dimethylamino, methyl, ethyl, butyl, dodecyl, methoxy, ethoxy, and cyclopropyl.
[0107] In more specific embodiments, the present disclosure provides the above method, wherein Ring A is substituted or unsubstituted phenyl, naphthyl, or thienyl, alternatively substituted or unsubstituted phenyl.
[0108] In more specific embodiments, the present disclosure provides an aryl group wherein R is H, halogen, C 1~6 Alkyl or C 1~6 As an alternative to the case of haloalkyl, the above process is provided where R is H or halogen.
[0109] In a more specific embodiment, the present disclosure provides a method for producing a pharmaceutical composition comprising: [ka] is selected from phenyl, naphthalen-1-yl, naphthalen-2-yl, 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl, 2-bromophenyl, 3-bromophenyl, 4-bromophenyl, 2,3-dichlorophenyl, 2,4-dichlorophenyl, 2,5-dichlorophenyl, 3,4-dichlorophenyl, 2,3,5-trichlorophenyl, 4-isopropylphenyl, and 4-t-butylphenyl, preferably [ka] is 2-chlorophenyl.
[0110] In a more specific embodiment, the present disclosure provides a C 1~6 alkyl.
[0111] In more specific embodiments, the present disclosure provides the above method, wherein R2 is H.
[0112] In a more specific embodiment, the present disclosure provides the above method wherein R3 is H, -CH3, -CH2CH3, -CH(CH3)2, -C(CH3)3, -CH2CH2H2CH3, phenyl, or -CH2-phenyl, preferably R3 is -CH3, -CH2CH3, -C(CH3)3, or -CH2-phenyl.
[0113] In a more specific embodiment, the present disclosure provides a method for preparing a phosphate buffer solution comprising the steps of: (a) preparing a phosphate buffer solution comprising: a) preparing a phosphate buffer solution comprising: a) preparing a phosphate buffer solution comprising: a) preparing a phosphate buffer solution comprising: a) preparing a phosphate buffer solution comprising: a) preparing a phosphate buffer solution comprising: a) preparing a phosphate buffer solution comprising: a) preparing a phosphate buffer solution comprising: a) preparing a phosphate buffer solution comprising: a) preparing a phosphate buffer solution comprising: a) preparing a phosphate buffer solution comprising: a) preparing a phosphate buffer solution comprising: a) preparing a phosphate buffer solution comprising: wherein the alkoxide is selected from alkali and alkaline earth metal alkoxides, such as aOMe, KOMe, NaOEt, KOEt, NaOtBu, KOtBu, triethylamine, DBU (1,8-diazabicyclo[5.4.0]undec-7-ene), DIPEA (N,N-diisopropylethylamine), DABCO (1,4-diazabicyclo[2.2.2]octane), and DMAP (4-dimethylaminopyridine), and organic amines.
[0114] In a more specific embodiment, the present disclosure provides the above method, wherein the reaction is carried out in the presence of a solvent selected from water, alkanes, ethers, esters, alcohols, halogenated hydrocarbons, ketones, amides, sulfones, sulfoxides, nitriles, and mixtures thereof, such as water, n-heptane, toluene, THF (tetrahydrofuran), MTBE (methyl tert-butyl ether), methyl tetrahydrofuran, ethyl acetate, isopropyl acetate, butyl acetate, methanol, ethanol, isopropanol, tert-butanol, tert-amyl alcohol, dichloromethane, 1,2-dichloroethane, chlorobenzene, acetone, 2-butanone, DMF (N,N-dimethylformamide), DMA (N,N-dimethylacetamide), NMP (N-methylpyrrolidone), DMSO (dimethylsulfoxide), and acetonitrile.
[0115] In a more specific embodiment, the present disclosure provides the above method, wherein the reaction temperature is from room temperature to the reflux temperature of the solvent, alternatively 40-90°C, and yet alternatively 50-80°C.
[0116] In a more specific embodiment, the present disclosure provides the above method, wherein the molar ratio of the compound of general formula (II) to the compound of general formula (III) is 1:(0.7-3), preferably 1:(0.7-1.5), more preferably 1:(1-1.2), and even more preferably 1:1, 1:1.05, 1:1.1, 1:1.15, or 1:1.2.
[0117] In a more specific embodiment, the present disclosure provides the above method, wherein the molar ratio of the compound of general formula (II) to the base is 1:(1-5), preferably 1:(2-4), more preferably 1:1.5, 1:1.6, 1:1.7, 1:1.8, 1:1.9, 1:2, 1:2.1, 1:2.2, 1:2.3, 1:2.4, 1:2.5, 1:2.6, 1:2.7, 1:2.8, 1:2.9, or 1:3.
[0118] In more particular embodiments, the methods of the present disclosure are carried out on an industrial scale.
[0119] The present disclosure also provides a compound of formula (I) produced by the process described above, [ka]
[0120] During the ceremony,
[0121] Ring A is C 6~10 aryl or 5-10 membered heteroaryl;
[0122] R1 is H, C 1~6 Alkyl, C 1~6 Haloalkyl, C 3~7 cycloalkyl, and 3- to 8-membered heterocyclyl;
[0123] R2 is H, C 1~6 Alkyl, and C 1~6 haloalkyl;
[0124] R3 is H, C 1~6 Alkyl, C 1~6 Haloalkyl, C 2~6 Alkenyl, C 2~6 Alkynyl, -C 0~6 Alkylene-C 3~7 Cycloalkyl, -C 0~6 Alkylene-3 to 8-membered heterocyclyl, -C 0~6 Alkylene-C 6~10 Aryl and -C 0~6 alkylene-5-10 membered heteroaryl, which are unsubstituted or independently substituted with m R′ groups;
[0125] R is H, halogen, -OC 1~6 Alkyl, C 1~6 Alkyl, and C 1~6 haloalkyl;
[0126] n is 0, 1, 2, 3, 4, or 5;
[0127] R' is halogen, -NO2, -CN, -NR a R b , -NR a C(O)R b , C 1~20 Alkyl, C 1~6 Haloalkyl, -OC 1~6 alkyl, and phenyl;
[0128] m is 1, 2, 3, 4, or 5;
[0129] R a and R b are independently H, C 1~6 Alkyl, C 1~6 Haloalkyl, C 3~7 Cycloalkyl, 3-8 membered heterocyclyl, C 6~10 aryl, and 5- to 10-membered heteroaryl, or R a and R b together with the nitrogen atom to which they are attached, form a 3- to 8-membered heterocyclyl or a 5- to 10-membered heteroaryl. EXAMPLES
[0130] The materials and reagents used herein are either commercially available or prepared by synthetic methods generally known in the art. The following reaction schemes illustrate the methods for the compounds of the present disclosure. It is an illustrative example of law in practice.
[0131] General operations
[0132] The reaction scheme and typical procedures for preparing compounds of general formula (I) are as follows: [ka]
[0133] The compound of formula (III), the base, the compound of formula (II), and the optional solvent are charged into a reactor, and the temperature is maintained between room temperature and the reflux temperature of the solvent. The mixture is stirred until the reaction is complete, during which the progress of the reaction is monitored. After the reaction is complete, the reaction solution is cooled to room temperature. The organic phase is separated and purified to obtain the compound of formula (I).
[0134] Compounds of general formula (II) are commercially available or can be prepared by methods known in the art. For example, the following route can be used: [ka]
[0135] A reactor is charged with a compound of general formula (IV), a compound of general formula (V), a base, and a solvent. The mixture is stirred at a certain temperature until the reaction is complete, during which the progress of the reaction is monitored. After completion of the reaction, the organic phase is separated. The organic phase may be used directly for the next reaction step, or may be evaporated to dryness for later use, or may be purified by rectification or column chromatography.
[0136] Alternatively, the compound of general formula (V) may be converted to an anhydride before reacting with the compound of general formula (IV) as described above.
[0137] Example 1 Preparation of ethyl 3-(2-chlorophenoxy)-2-butenoate [ka]
[0138] (1) Ethyl acetoacetate (50.0 g, 384 mmol, 1.0 equiv.), triethylamine (38.8 g, 384 mmol, 1 equiv.), DABCO (17.2 g, 154 mmol, 0.4 equiv.), and 250 mL of isopropyl acetate were charged to a reactor, followed by the dropwise addition of a solution of p-toluenesulfonyl chloride (87.8 g, 460.8 mmol, 1.2 equiv.) in isopropyl acetate (250 mL) at 0-10° C. over 1-2 hours. After completion of the addition, the mixture was allowed to react with stirring at 10-20° C. for 3 hours. After completion of the reaction, the reaction was quenched by adding 250 mL of water. The organic phase was separated and washed with 250 mL of 5% p-toluenesulfonic acid solution and 250 mL of 8% sodium bicarbonate solution, respectively, to give a solution of ethyl 3-(p-toluenesulfonyloxy)-2-butenoate in isopropyl acetate (yield 98.7% (external standard method)), which was either evaporated to dryness (purity 99.2%) or used directly in the next reaction.
[0139] (2) Potassium carbonate (150 g, 1.09 mol, 2.8 equiv.), 350 mL of isopropyl acetate, and the solution of ethyl 3-(p-toluenesulfonyloxy)-2-butenoate in isopropyl acetate from step (1) were charged to the reactor. The mixture was heated to 70-80° C., followed by the dropwise addition of a solution of 2-chlorophenol (50 g, 0.389 mmol, 1.0 equiv.) in isopropyl acetate (400 mL) at 70-80° C. over 2-3 hours. After the addition was complete, the mixture was allowed to react with stirring at 70-80° C. for an additional 19 hours. The reaction mixture was cooled to room temperature and quenched by the addition of water. The organic phase was isolated as a 94.9% pure solution of ethyl 3-(2-chlorophenoxy)-2-butenoate in isopropyl acetate. The above solution of ethyl 3-(2-chlorophenoxy)-2-butenoate in isopropyl acetate was concentrated to give 99.7 g of crude product (containing 85.4% product) for a combined yield of 92.1% over the two steps.
[0140] 1H-NMR(CDCl3,400MHz):δ7.46-7.48(m,1H),7.29-7.33(m,1H),7.21-7.23(m,1H),7 .10-7.11(m,1H),4.78(s,1H),4.11(q,2H,J=4.2),2.54(s,3H),1.23(t,3H,J=4.2)
[0141] Examples 2 to 15 The corresponding compounds were prepared according to the method of Example 1 using the reagents or groups in the following table. [ka] [Table 1-1] [Table 1-2]
[0142] Note: IPrOAc: isopropyl acetate; DMF: N,N-dimethylformamide; Bn: benzyl; DABCO: 1,4-diazabicyclo[2.2.2]octane; n-Hep: n-heptane; Me-THF: 2-methyltetrahydrofuran
[0143] Example 6: tert-butyl 3-(2-chlorophenoxy)-2-butenoate, 1 H-NMR(CDCl3,400MHz):δ7.36-7.38(m,1H),7.19-7.21(m,1H),7.10-7.11(m,1H),7.01-7.03(m,1H),4.61(s,1H),2.46(s,3H),1.35(s,9H)
[0144] Example 7: Benzyl 3-(2-chlorophenoxy)-2-butenoate, 1H-NMR(CDCl3,400MHz):δ7.33-7.35(m,1H),7.20-7.32(m,6H),7.17-7.21(m,1H),7.00-7.10(m,1H),4.99(s,2H),4.72(s,1H),2.46(s,3H)
[0145] The above describes the present invention in more detail in relation to certain preferred embodiments, and it cannot be assumed that the specific embodiments of the present invention are limited to these descriptions. It is obvious to those skilled in the art that the present disclosure may be practiced by making various simple omissions and substitutions without departing from the spirit and scope of the present invention.
Claims
1. A process for preparing a compound of general formula (I), comprising reacting a compound of general formula (II) with a compound of general formula (III) in the presence of a base, [Formula 1] During the ceremony, Ring A is C 6~10 aryl or 5- to 10-membered heteroaryl; X is S; R 1 is C 1~6 Alkyl, and C 1~6 haloalkyl; R 2 is H, R 3 is H, C 1~6 Alkyl, C 1~6 Haloalkyl, C 2~6 Alkenyl, C 2~6 Alkynyl, -C 0~6 Alkylene-C 3~7 Cycloalkyl, -C 0~6 alkylene-3 to 8 membered heterocyclyl, -C 0~6 Alkylene-C 6~10 Aryl, and -C 0~6 alkylene-5-10 membered heteroaryl, said groups being unsubstituted or independently substituted with m R′ groups; R 4 is C 1~20 Alkyl, C 1~6 Haloalkyl, -OR a , -NR a R b , C 3~7 Cycloalkyl, 3-8 membered heterocyclyl, C 6~10 aryl, and 5-10 membered heteroaryl, which are unsubstituted or independently substituted with m′ R″ groups; R is H, halogen, or —O—C 1~6 Alkyl, C 1~6 Alkyl, and C 1~6 haloalkyl; n is 0, 1, 2, 3, 4, or 5; R′ and R″ are independently halogen, —NO 2 , -CN, -NR a R b , -NR a C(O)R b , C 1~20 Alkyl, C 1~6 Haloalkyl, —O—C 1~6 alkyl, and phenyl; m is 1, 2, 3, 4, or 5; m′ is 1, 2, 3, 4, or 5; R a and R b are independently H, C 1~6 Alkyl, C 1~6 Haloalkyl, C 3~7 Cycloalkyl, 3-8 membered heterocyclyl, C 6~10 aryl, and 5- to 10-membered heteroaryl, or R a and R b together with the nitrogen atom to which they are attached form a 3- to 8-membered heterocyclyl or a 5- to 10-membered heteroaryl; method.
2. R 4 is unsubstituted or independently substituted with m′ R″ groups; 6~10 The method according to claim 1, wherein the aryl is an aryl or a 5-10 membered heteroaryl.
3. R 4is selected from phenyl, 1-naphthyl, 2-naphthyl, 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl, 2-bromophenyl, 3-bromophenyl, 4-bromophenyl, 2-fluorophenyl, 3-fluorophenyl, 4-fluorophenyl, 2,6-dichlorophenyl, 2,4-difluorophenyl, 3-cyanophenyl, 4-cyanophenyl, 2-nitrophenyl, 4-nitrophenyl, 2-methylphenyl, 4-methylphenyl, 4-propylphenyl, 4-t-butylphenyl, 2,5-dimethylphenyl, mesityl, 2,4,6-triisopropylphenyl, 2-dodecylphenyl, 3-dodecylphenyl, 4-dodecylphenyl, 2-(trifluoromethyl)phenyl, 3-(trifluoromethyl)phenyl, 3,5-bis(trifluoromethyl)phenyl, 4-methoxyphenyl, N,N-dimethylaminophenyl, 4-acetylaminophenyl, 4-biphenyl, thienyl, and 5-bromothienyl, preferably R 4 is selected from phenyl, 1-naphthyl, 2-naphthyl, 4-chlorophenyl, 3-fluorophenyl, 4-fluorophenyl, 4-nitrophenyl, 2-methylphenyl, 4-propylphenyl, 4-t-butylphenyl, 2,5-dimethylphenyl, 2,4,6-triisopropylphenyl, 2-dodecylphenyl, 3-dodecylphenyl, 4-dodecylphenyl, 4-methoxyphenyl, 4-acetylaminophenyl, 4-methylphenyl, and mesityl, more preferably R 4 The method of claim 2, wherein is selected from phenyl, 4-chlorophenyl, 4-methylphenyl, and mesityl.
4. R 4 is unsubstituted or independently substituted with m′ R″ groups; 1~12 Alkyl, -OR a , -NR a R b , C 3~7 The method of claim 1, wherein the aryl group is cycloalkyl or 3-8 membered heterocyclyl.
5. R 4The method of claim 4, wherein is selected from N,N-dimethylamino, methyl, ethyl, butyl, dodecyl, methoxy, ethoxy, and cyclopropyl.
6. The method according to any one of claims 1 to 5, wherein Ring A is phenyl, naphthyl or thienyl, preferably phenyl.
7. R is H, halogen, C 1~6 Alkyl, or C 1~6 The method according to any one of claims 1 to 6, wherein R is haloalkyl, preferably R is H or halogen.
8.
2. is selected from phenyl, naphthalen-1-yl, naphthalen-2-yl, 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl, 2-bromophenyl, 3-bromophenyl, 4-bromophenyl, 2,3-dichlorophenyl, 2,4-dichlorophenyl, 2,5-dichlorophenyl, 3,4-dichlorophenyl, 2,3,5-trichlorophenyl, 4-isopropylphenyl, and 4-t-butylphenyl, preferably [C3] The method of any one of claims 1 to 7, wherein is 2-chlorophenyl.
9. R 1 However, C such as methyl 1~6 The method according to any one of claims 1 to 8, wherein the alkyl group is selected from alkyl.
10. R 3 is H, -CH 3 , -CH 2 CH 3 , -CH(CH 3 ) 2 , -C(CH 3 ) 3 , -CH 2 CH 2 H 2 CH 3 , phenyl, or -CH 2 -phenyl, preferably R 3But -CH 3 , -CH 2 CH 3 , -C(CH 3 ) 3 , or -CH 2 -phenyl.
11. The base is selected from inorganic bases and organic bases, preferably the inorganic base is selected from carbonates, hydrogen carbonates, phosphates, hydrogen phosphates, dihydrogen phosphates, hydroxides and hydrides of alkali metals and alkaline earth metals, such as LiOH, NaOH, KOH, Li 2 CO 3 , Na 2 CO 3 , K 2 CO 3 , Cs 2 CO 3 , Na 3 P.O. 4 , K 3 P.O. 4 , K 2 H.P.O. 4 , K.H. 2 P.O. 4 and NaH, preferably, said organic base is selected from alkali metal and alkaline earth metal alkoxides, and organic amines.
12. The method of claim 11, wherein the organic base is selected from NaOMe, KOMe, NaOEt, KOEt, NaOtBu, KOtBu, triethylamine, DBU, DIPEA, DABCO, and DMAP.
13. 13. The process according to any one of claims 1 to 12, wherein the reaction is carried out in the presence of a solvent selected from water, alkanes, toluene, ethers, esters, alcohols, halogenated hydrocarbons, ketones, amides, sulfones, sulfoxides, nitriles, and mixtures thereof.
14. The method of claim 13, wherein the reaction is carried out in the presence of a solvent selected from water, n-heptane, toluene, THF, MTBE, methyltetrahydrofuran, ethyl acetate, isopropyl acetate, butyl acetate, methanol, ethanol, isopropanol, tert-butanol, tert-amyl alcohol, dichloromethane, 1,2-dichloroethane, chlorobenzene, acetone, 2-butanone, DMF, DMA, NMP, DMSO, and acetonitrile, and mixtures thereof.
15. The process according to any one of claims 1 to 14, wherein the reaction temperature is from room temperature to the reflux temperature of the solvent, preferably from room temperature to the reflux temperature of the solvent and from 40 to 90°C, more preferably from room temperature to the reflux temperature of the solvent and from 50 to 80°C.
16. The method according to any one of claims 1 to 15, wherein the molar ratio of the compound of general formula (II) to the compound of general formula (III) is 1:(0.7 to 3), preferably 1:(0.7 to 1.5), more preferably 1:(1 to 1.2), even more preferably 1:1, 1:1.05, 1:1.1, 1:1.15, or 1:1.
2.
17. 17. The process according to any one of claims 1 to 16, wherein the molar ratio of the compound of general formula (II) to the base is 1:(1-5), preferably 1:(2-4), more preferably 1:1.5, 1:1.6, 1:1.7, 1:1.8, 1:1.9, 1:2, 1:2.1, 1:2.2, 1:2.3, 1:2.4, 1:2.5, 1:2.6, 1:2.7, 1:2.8, 1:2.9, or 1:3.
Citation Information
Patent Citations
Production of 3,6-dichloro-2-hydroxyacetophenone
JP1987045549A
Pyrimidine or triazine derivative and herbicide
JP1992356469A
alpha,beta-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL AGENT CONTAINING THE SAME
JP2009227655A
Pyrrolidinone glucokinase activator
JP2011517692A
Inhibitor(s) of transporters or uptake of monoaminergic neurotransmitters
WO2011011277A1
